Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GACHE trial of dexamethasone added to acyclovir for herpes simplex virus encephalitis
NL-OMON30943Not yet recruiting
- Sponsor
- Heidelberg University
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in herpetic meningoencephalitis (HME) comparing Dexamethasone plus acyclovir with Placebo plus acyclovir (2 arms). Primary endpoint: Binary functional outcome at 6 months. Planned start Aug 2007; status: not yet recruiting.
02
Drugs
dexamethasoneaciclovir
03
Conditions
herpetic meningoencephalitis (HME)
Beyond the preview
Go deeper on NL-OMON30943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30943.